Scienmag

SEPTEMBER 24, 2020

DrBioRight uses natural-language interface to facilitate intuitive data analysis for broader research community Credit: The University of Texas MD Anderson Cancer Center HOUSTON — A new data analysis tool developed by researchers at The University of Texas MD Anderson Cancer Center incorporates a user-friendly, natural-language interface to allow (..)

Bioinformatics 48

Bioinformatics Big Data Research Development 48

Scienmag

AUGUST 4, 2020

Led by Boyce Thompson Institute’s Andrew Nelson, four partners will identify RNA modifications and develop resources that may lead to hardier crops Credit: Photo credit: Anna Nelson Dittrich ITHACA, NY, August 4, 2020 — RNA perform a variety of functions in cells, helping with everything from regulating genes to building proteins.

RNA 74

RNA Bioinformatics Protein Regulation 74

Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. The collaboration will expedite the discovery of drugs and expand the use of investigations for cancer treatments.

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

Drug Discovery World

SEPTEMBER 14, 2023

Immatics will also receive research funding and is eligible to receive development, regulatory, and commercial milestone payments that could exceed $1.7 Moderna will lead the clinical development and commercialisation of cancer vaccines and TCER therapeutics resulting from the collaboration.

Development 52

Development Vaccination Vaccine In-Vivo 52

BioTech 365

DECEMBER 3, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop a sequence analysis pipeline for virus discovery.Researchers from the University of Helsinki have developed a novel bioinformatics pipeline called Lazypipe for identifying viruses in host-associated … (..)

Bioinformatics 40

Bioinformatics Development Research 40

pharmaphorum

SEPTEMBER 16, 2022

With approximately one third of all current FDA-approved drugs targeting GPCRs, Verily/Sosei Heptares are looking to expedite GPCR research within not only immunology, but also gastroenterology and immuno-oncology as well, and the latest data bodes well for future development of therapeutic options in these areas.

Development 135

Development Research Drugs Clinical Trials 135

Scienmag

FEBRUARY 4, 2021

Applications in Plant Sciences… SSRgenotyper is a newly developed, free bioinformatic tool that allows researchers to digitally genotype sequenced populations using simple sequence repeats (SSRs), a task that […].

Genotype 90

Genotype Bioinformatics Genome Genomics 90

Scienmag

APRIL 12, 2022

Researchers at The University of Texas MD Anderson Cancer Center have developed a new bioinformatics platform that predicts optimal treatment combinations for a given group of patients based on co-occurring tumor alterations. Abstract: LB119 Credit: MD Anderson Cancer Center Abstract: LB119 NEW ORLEANS ?

Bioinformatics 82

Bioinformatics Development Research 82

Medical Xpress

NOVEMBER 8, 2022

A team of researchers at Indiana University School of Medicine has developed specialized bioinformatics software designed to identify rare genetic variants in whole-genome sequencing studies. Zilin Li, Ph.D.,

Genetics 75

Genetics Bioinformatics Genome Genomics 75

Drug Discovery World

JULY 5, 2023

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 29, 2023

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 22, 2023

This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

FEBRUARY 8, 2024

The event aimed to help the audience understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

Drug Discovery World

FEBRUARY 17, 2023

The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of new treatments.

Bioinformatics 52

Bioinformatics Drugs Genome Genomics 52

Drug Discovery World

FEBRUARY 17, 2023

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments. The post Partners hope to “chart a new era of drug discovery” appeared first on Drug Discovery World (DDW).

Bioinformatics 52

Bioinformatics Drugs Licensing Licensing 52

Scienmag

MAY 4, 2021

Mohsin Jafri, Director, Neuroscience Program; Professor Bioinformatics/Computational Biology, is studying cancer drug susceptibility. This technology may be applied to data extracted from the molecular […].

Bioinformatics 72

Bioinformatics Drugs Genetics Development 72

Scienmag

JUNE 28, 2021

McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia, is leading a dynamic, new $6.2 Credit: Michael Holahan, Augusta University Dr. Richard A.

Bioinformatics 75

Bioinformatics Research Genome Genomics 75

Scienmag

JUNE 10, 2021

million from the National Institute of Child Health and Human Development to develop an automated risk assessment (ARIA) system, which is designed to detect and prevent school violence. Credit: Cincinnati Children’s CINCINNATI – Scientists at Cincinnati Children’s have been awarded a five-year grant totaling $2.8

Development 94

Development Scientist Bioinformatics Engineer 94

Drug Discovery World

OCTOBER 3, 2023

The event aimed to help the audience understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Life Science Bioinformatics 52

Scienmag

MAY 24, 2021

The ultimate goal of the conference is to bring together bioinformaticians and biologists to share experience in development and practical application of bioinformatics algorithms. […]. Breakthrough results in these fields can only be achieved by tight communication and knowledge exchange between the two sides.

Bioinformatics 40

Bioinformatics Life Science Development 40

Scienmag

NOVEMBER 18, 2020

Credit: SDSU For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.

Bacterium 88

Bacterium Development Research Bioinformatics 88

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. .

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

APRIL 15, 2021

When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. In the very early phase of development, Astellas also participates in public-private partnerships with academia, regulators, experts and beyond. The impact of COVID-19 and implications for the future.

Development 76

Development Manufacturing Production Bioinformatics 76

Drug Discovery World

JUNE 14, 2023

Unlocking their secrets requires complex bioinformatic exploration. To this end, Evotec has developed PanHunter, a platform that combines peer-reviewed statistical analysis algorithms with the potential of machine learning and artificial intelligence.

Bioinformatics 52

Bioinformatics Research Development Drugs 52

Drug Discovery World

JUNE 14, 2023

Unlocking their secrets requires complex bioinformatic exploration. To this end, Evotec has developed PanHunter, a platform that combines peer-reviewed statistical analysis algorithms with the potential of machine learning and artificial intelligence.

Bioinformatics 52

Bioinformatics Research Development Drugs 52

BioTech 365

FEBRUARY 5, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: SSRgenotyper: A new tool to digitally genotype simple sequence repeats.SSRgenotyper is a newly developed, free bioinformatic tool that allows researchers to digitally genotype sequenced populations using simple … Continue (..)

Genotype 40

Genotype Bioinformatics Research Development 40

Drug Discovery World

JULY 11, 2023

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. How AI and ML are influencing drug development Biopharma has experienced significant growth in using these technologies for the past 10 years.

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

MAY 16, 2023

New South African company NewBiologix has launched with the aim of developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies.

Production 52

Production Gene Therapy Gene Bioinformatics 52

Drug Discovery World

SEPTEMBER 29, 2023

PandaOmics integrates multiple omics and text-based AI bioinformatics models to assess the potential of proteins as therapeutic targets. By modulating the formation and behaviour of these condensates, it may be possible to develop novel interventions to mitigate the pathological processes associated with Alzheimer’s disease.

Protein 69

Protein Bioinformatics Medicine Engineer 69

Rethinking Clinical Trials

FEBRUARY 28, 2024

But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. from 2021 to 2026.

Clinical Trials 146

Clinical Trials Clinical Trials Trials Clinical Research 146

pharmaphorum

JULY 5, 2022

The new partnership will apply Mogrify’s cellular reprogramming and bioinformatics expertise to try to identify transcription factors – proteins which can turn specific genes on or off – that can be used to generate new cochlear hair cells. An estimated 1.57

In-Vivo 110

In-Vivo Bioinformatics Genetics Licensing 110

Scienmag

APRIL 27, 2021

Credit: Nigel Michki Neurons result from a highly complex and unique series of cell divisions. For example, in fruit flies, the process starts with stem cells that divide into mother cells (progenitor cells), that then divide into precursor cells that eventually become neurons.

RNA 98

RNA Scientist Gene Development 98

pharmaphorum

JULY 20, 2022

The two organisations have previously collaborated on the creation of three cancer therapeutics companies, including bacterial delivery system developer Neobe therapeutics, oncolytic virus therapy company Stratosvir, and bioinformatics specialist Enedra.

Research 84

Research Bioinformatics Gene Therapy Medicine 84

Scienmag

MAY 19, 2021

Credit: Dr Oli Tills, University of Plymouth Scientists have made a major breakthrough in the study of embryonic development and how it can be impacted by external factors such as climate change.

Development 40

Development Scientist Research Bioinformatics 40

Drug Discovery World

MAY 1, 2024

This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 These enable researchers to better manipulate biological molecules or identify the best candidates to progress to the next stage of development.

Antibody 59

Antibody FDA Approval Drugs Development 59

pharmaphorum

APRIL 1, 2021

We speak to the company’s CEO and co-founder, Szabolcs Nagy, to find out why moving beyond traditional biotech drug development is a good fit for the country’s ecosystem. They go into bioinformatics”. It’s incredibly exciting to see what can be done with the right data and digital expertise combined with experienced drug developers.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

Drug Discovery World

AUGUST 29, 2022

Dr Navar holds a PhD in Medicine from Leiden University, and an MSc in Bioinformatics and Artificial Intelligence from Brunel University. . How can automation push the development of biologics and biosimilars? . The event will take place on 4-5 Oct, London Excel, UK and additional topics will include: . The sustainable lab.

Drugs 52

Drugs Bioinformatics Medicine Scientist 52